
Monday Jun 17, 2024
Durvalumab’s Benefit in SCLC ”Beyond What We Might Have Expected”
From ASCO 2024, Dr. Robert Figlin talks with Dr. Lauren Averett Byers from MD Anderson Cancer Center.
Durvalumab's Benefit in SCLC "Beyond What We Might Have Expected"
No comments yet. Be the first to say something!